- Logic: niche depth matters more than scale
- Materials: product, R&D, supply-chain evidence
- Pitfall: patent counts without a capability story
1. The real question is irreplaceability
The Little Giant assessment is not a contest of how large a company is. It asks how deep a company is in a specific segment. Reviewers look for three things: whether the core product has long focused on a defined niche, whether R&D investment is sustained, and whether the company has entered the supply systems of leading customers or key industrial chains. These three form a logical chain—focus creates accumulation, accumulation creates technical barriers, and barriers create supply-chain standing. If application materials are merely stacks of certificates, patents and financial statements, reviewers see fragments. If organized along this chain, they see capability.
Since the Private Economy Promotion Law took effect on May 20, 2025, institutional support for private-sector innovation and fair competition has become clearer, and the specialized, refined, distinctive and innovative (SRDI) cultivation system is a key part of that framework. For applicants, policy expectations are more stable, but review standards have not loosened; if anything, they emphasize verifiability and authenticity.
2. Organizing three evidence chains
First, the core product chain. Companies must clearly state what the core product is, its share of revenue, which niche it serves, and what specific customer problem it solves. The biggest mistake is broad descriptions such as "intelligent manufacturing solutions," which make focus hard to judge. A narrow definition—a specific component, process, or software module—works better.
Second, the R&D evidence chain. R&D spending ratios and researcher headcount are hard indicators, but they are supported by process evidence: project approval documents, auxiliary R&D expense ledgers, the mapping between patents and products, test reports and user validation. A common problem is having many patents but being unable to explain which patent maps to which product and which technical difficulty it resolves. Reviewers care more about the patent-product-customer link than about the sheer number of certificates.
Third, proof of industrial-chain value. This includes supplier qualifications from leading customers, supporting contracts, and application certificates from industry associations or downstream firms. For smaller companies this is especially important because it translates technical capability into industrial value. Without direct entry into major customer systems, companies can cite niche market share, import-substitution cases, or participation in standards.
3. Common pitfalls and preparation rhythm
The first pitfall is treating the application as a last-minute annual push. Auxiliary R&D ledgers, project initiation, and IP layout require multi-year accumulation; last-minute materials often create timeline inconsistencies. The second is valuing form over substance—turning materials into a brochure while ignoring data consistency. Revenue, R&D expenses, and headcount must reconcile across tables. The third is a poorly defined niche: too broad and focus is unconvincing; too narrow and credibility suffers. Anchor the definition in authoritative industry reports or association data.
On timing, start a year ahead: map the core product and revenue structure, standardize R&D expense collection, and inventory the patent-to-product mapping. The application is not the end point; it is a systematic review of capability.
Conclusion
The value of the Little Giant designation lies not only in the title but in the process of forcing a company to articulate why it is irreplaceable. A company that can tell that story clearly has already calibrated its capabilities, even if it is not designated this year. With a stable policy window, earlier preparation means more confident materials.